Marex Group »

Bicycle Therapeutics shares owned by Marex Group

Quarter-by-quarter ownership of Bicycle Therapeutics (BCYC) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Bicycle Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicycle Therapeutics held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicycle Therapeutics by Marex Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $534k 115k 4.64
2025-12-31 $555k 78k 7.08

More positions owned by Marex Group

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Broadcom (AVGO)
Lumentum Hldgs Put Option (LITE)
Microsoft Corporation Call Option (MSFT)
Mastercard Incorporated Cl A Put Option (MA)
UnitedHealth (UNH)
Strategy Cl A New (MSTR)
Tesla Motors (TSLA)
Eli Lilly & Co. Put Option (LLY)
Goldman Sachs Put Option (GS)
Booking Holdings (BKNG)
Sandisk Corp (SNDK)
NVIDIA Corporation Call Option (NVDA)
Valkyrie Bitcoin (BRRR)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Marex Group

Top funds holding Bicycle Therapeutics

Baker Bros. Advisors
Fcpm Iii Services B.v.
Armistice Capital
Long Focus Capital Management
Siren
Acadian Asset Management
Principal Financial Group
Morgan Stanley
Schroder Investment Management Group
Bnp Paribas Investment Partners
Renaissance Technologies
Silvercrest Asset Management Group
Birchview Capital
Citadel Advisors
Jane Street

View all funds holding Bicycle Therapeutics